Rituximab as a Treatment for Limbic Encephalitis Associated with Leucine-Rich Glioma Inactivated 1: A Case Report and Literature Review

Rituximab as a Treatment for Limbic Encephalitis Associated with Leucine-Rich Glioma Inactivated 1: A Case Report and Literature Review

Leucine-rich glioma-inactivated-1 (LGI1) protein antibody-associated limbic encephalitis (LE) is a treatable autoimmune disease. This report is about the administration of rituximab in two patients with LGI1 antibody-associated LE. Both patients had progressive confusion, behavioral alteration, memo...

Full description

Bibliographic Details
Main Authors: Behnam Safarpour LIMA, Mahtab RAMEZANI, Ehsan KARIMIALAVIJEH, Sepideh PAYBAST, Nahid BELADIMOGHADAM, Nikoo Hossein Khan NAZER
Format: Article
Language:English
Published: Third Party Medicine International Publishing Group Co. Limited 2019-04-01
Series:Journal of International Translational Medicine
Subjects:
Rituximab
Leucine rich glioma inactivated protein 1
Limbic encephalitis
Treatment
Online Access:http://dx.doi.org/10.11910/2227-6394.2019.07.01.15

Similar Items

Similar Items